TPMT and hearing loss disorder: Because of that, the Food and Drug Administration (FDA) had issued a special precaution on cisplatin drug labels stating that individuals with allele TPMT*3B and TPMT*3C (*3A is haplotype of *3B and *3C) are at a higher risk of hearing loss [270].